Edwards Lifesciences Corp (NYSE:EW)

CAPS Rating: 4 out of 5

A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies.


Player Avatar gopyerk (92.97) Submitted: 12/4/2012 10:37:22 AM : Outperform Start Price: $89.34 EW Score: -38.21

Right in the middle of the 52 week range with very positive outlook today from the CEO, despite the bounce from the news I like the upshot here. Bought in R/L at $88 this morning...

Featured Broker Partners